Use of Image-Guided Surgical Navigation during Resection of Locally Recurrent Rectal Cancer.

image-guided surgical navigation locally recurrent rectal cancer

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
27 Apr 2022
Historique:
received: 17 03 2022
revised: 21 04 2022
accepted: 22 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

Surgery for locally recurrent rectal cancer (LRRC) presents several challenges, which is why the percentage of inadequate resections of these tumors is high. In this exploratory study, we evaluate the use of image-guided surgical navigation during resection of LRRC. Patients who were scheduled to undergo surgical resection of LRRC who were deemed by the multidisciplinary team to be at a high risk of inadequate tumor resection were selected to undergo surgical navigation. The risk of inadequate surgery was further determined by the proximity of the tumor to critical anatomical structures. Workflow characteristics of the surgical navigation procedure were evaluated, while the surgical outcome was determined by the status of the resection margin. In total, 20 patients were analyzed. For all procedures, surgical navigation was completed successfully and demonstrated to be accurate, while no complications related to the surgical navigation were discerned. Radical resection was achieved in 14 cases (70%). In five cases (25%), a tumor-positive resection margin (R1) was anticipated during surgery, as extensive radical resection was determined to be compromised. These patients all received intraoperative brachytherapy. In one case (5%), an unexpected R1 resection was performed. Surgical navigation during resection of LRRC is thus safe and feasible and enables accurate surgical guidance.

Identifiants

pubmed: 35629313
pii: life12050645
doi: 10.3390/life12050645
pmc: PMC9143650
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Vriendenloterij
ID : NKI2016-8162

Commentaires et corrections

Type : ErratumIn

Références

Comput Aided Surg. 2010;15(1-3):1-12
pubmed: 20233129
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1460-6
pubmed: 11503316
Eur J Surg Oncol. 2017 Jan;43(1):107-117
pubmed: 27659000
Ann Surg. 2015 Dec;262(6):891-8
pubmed: 26473651
Eur J Surg Oncol. 2020 Mar;46(3):448-454
pubmed: 31761506
World Neurosurg. 2022 Apr;160:e404-e411
pubmed: 35033690
N Engl J Med. 2015 Apr 2;372(14):1324-32
pubmed: 25830422
Br J Surg. 2014 Sep;101(10):1280-9
pubmed: 25049111
Acta Neurochir (Wien). 2019 May;161(5):865-870
pubmed: 30879130
J Surg Oncol. 2021 Dec;124(7):1173-1181
pubmed: 34320228
Ann Surg. 2019 Feb;269(2):211-220
pubmed: 29697448
Eur J Surg Oncol. 2020 Jun;46(6):1131-1137
pubmed: 32224071
Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1444-9
pubmed: 19395199
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Ann Surg Oncol. 2015 Aug;22(8):2677-84
pubmed: 25564165
Ann Transl Med. 2021 Jun;9(12):1026
pubmed: 34277826
J Surg Oncol. 2019 Mar;119(4):510-517
pubmed: 30582622
JAMA Netw Open. 2020 Jul 1;3(7):e208522
pubmed: 32639566
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Lancet. 2018 Jun 23;391(10139):2537-2545
pubmed: 29976470
J Clin Oncol. 2011 Dec 10;29(35):4633-40
pubmed: 22067400
Ann Surg Oncol. 2008 Jul;15(7):1937-47
pubmed: 18389321
Dis Colon Rectum. 2015 Jul;58(7):677-85
pubmed: 26200682
J Natl Cancer Inst. 2016 Aug 10;108(12):
pubmed: 27509881
Lancet. 2009 Sep 26;374(9695):1105-12
pubmed: 19782876
Neurosurgery. 1999 Jan;44(1):97-104; discussion 104-5
pubmed: 9894969

Auteurs

Harald C Groen (HC)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Anne G den Hartog (AG)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Wouter J Heerink (WJ)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Koert F D Kuhlmann (KFD)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Niels F M Kok (NFM)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Ruben van Veen (R)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Marijn A J Hiep (MAJ)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Petur Snaebjornsson (P)

Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Brechtje A Grotenhuis (BA)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Geerard L Beets (GL)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Arend G J Aalbers (AGJ)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Theo J M Ruers (TJM)

Department of Surgical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Faculty of Science and Technology (TNW), Nanobiophysics Group (NBP), University of Twente, 7500 AE Enschede, The Netherlands.

Classifications MeSH